Categories: News

Springer Nature honours Indian editors at Journal Development Symposium 2025. Brings Together Leading Editors and Publishing Experts to Shape the Future of Research Integrity and AI in Scholarly Communication

NEW DELHI, Oct. 31, 2025 /PRNewswire/ — The day long Journal Development Symposium 2025, organised by Springer Nature, brought together over 100 journal editors, society representatives, and publishing professionals from across India to discuss the evolving dynamics of research publishing in the age of Artificial Intelligence (AI) and Open Access.

- Advertisement -

The symposium served as a collaborative platform for dialogue around ethical publishing practices, the responsible integration of AI tools in scholarly workflows, and the broader implications of India’s transformative One Nation One Subscription (ONOS) initiative.

- Advertisement -

In her keynote address, Marieke Cambeen, Executive Vice President, Springer Journals, highlighted the growing role of publishers in upholding research quality in an AI-driven era. She said: “As AI continues to increasingly integrate into every stage of the research process, from writing and reviewing to editorial decision-making, it is essential for the publishing community to come together to establish ethical, transparent, and inclusive frameworks. Through initiatives like the Journal Development Symposium, we aim to strengthen collaboration between publishers, editors, and the research community to ensure integrity and trust remain at the heart of scientific publishing.”

- Advertisement -

The day-long event featured a series of engaging sessions, including a presentation on ‘ONOS and Beyond’ followed by a Journals Award Ceremony celebrating outstanding editorial contributions. Some editors also shared Journal Success Stories that demonstrated innovative editorial strategies and growth in journal impact and reach.

- Advertisement -

The Open Forum Discussion encouraged participants to exchange perspectives on journal development challenges, AI’s influence on publishing ethics, and the opportunities presented by Open Access models in India’s rapidly evolving research landscape.

- Advertisement -

The symposium reaffirmed Springer Nature’s ongoing commitment to supporting journal editors and society partners in advancing quality research, fostering innovation, and promoting responsible science communication globally.

- Advertisement -

About Springer Nature:

- Advertisement -

Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world. For more information, please visit about.springernature.com and @SpringerNature.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2810380/JDS_2025_Springer_Nature.jpg
Logo – https://mma.prnewswire.com/media/2578536/5594531/Springer_Nature_Logo.jpg

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/springer-nature-honours-indian-editors-at-journal-development-symposium-2025-brings-together-leading-editors-and-publishing-experts-to-shape-the-future-of-research-integrity-and-ai-in-scholarly-communication-302601118.html

- Advertisement -

Recent Posts

Medanta Expands Indore Presence with Takeover of 80 Bed Cancer Hospital

GURUGRAM, India, April 27, 2026 /PRNewswire/ -- Global Health Limited 'Medanta', one of the largest…

24 minutes ago

The EXCEL – First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

PARIS, April 27, 2026 /PRNewswire/ -- A new study has established that treatment with essential phospholipids…

24 minutes ago

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801…

24 minutes ago

CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026

LONDON, April 27, 2026 /PRNewswire/ -- Concept Medical Inc., today announced the presentation of preliminary…

24 minutes ago

Bombay Founders’ Club Acquires Movement, previously ‘The Indian Startup Community’

The announcement was made at 'The Room' Event in MumbaiMUMBAI, India, April 27, 2026 /PRNewswire/…

3 hours ago

KuCoin Hosts HEXAGON BLOCK PARTY at Hong Kong Web3 Festival, Headlined by DJ Don Diablo and Rooted in Shared Values of Community and Connection

Headlined by internationally renowned DJ Don Diablo, the event brought together guests from the Web3…

3 hours ago